| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.17B | 963.64M | 776.95M | 585.94M | 387.86M |
| Gross Profit | 866.84M | 706.17M | 547.28M | 383.53M | 250.57M |
| EBITDA | -310.37M | -397.06M | -430.01M | -455.05M | -335.99M |
| Net Income | -295.27M | -345.06M | -442.75M | -452.55M | -342.80M |
Balance Sheet | |||||
| Total Assets | 2.99B | 2.69B | 2.46B | 2.34B | 2.34B |
| Cash, Cash Equivalents and Short-Term Investments | 2.05B | 1.91B | 1.90B | 1.93B | 2.02B |
| Total Debt | 1.11B | 1.11B | 1.11B | 1.12B | 1.12B |
| Total Liabilities | 1.82B | 1.73B | 1.65B | 1.58B | 1.49B |
| Stockholders Equity | 1.17B | 961.23M | 810.41M | 769.48M | 850.28M |
Cash Flow | |||||
| Free Cash Flow | 60.68M | 9.49M | -124.34M | -171.79M | -114.00M |
| Operating Cash Flow | 64.27M | 33.46M | -103.66M | -157.33M | -105.06M |
| Investing Cash Flow | -185.00M | -74.98M | -84.85M | -865.80M | -400.58M |
| Financing Cash Flow | 81.19M | 79.81M | 102.37M | 82.24M | 1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $29.55B | -403.50 | -3.23% | ― | 20.93% | 68.47% | |
65 Neutral | $1.76B | -2,528.21 | 0.04% | ― | -11.61% | 99.07% | |
62 Neutral | $104.81B | ― | -8.88% | ― | 22.05% | -341.24% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $10.97B | -35.78 | -27.72% | ― | 21.58% | 18.88% | |
60 Neutral | $14.70B | 75.10 | 2.96% | ― | 12.12% | ― | |
57 Neutral | $66.97B | ― | -8.16% | ― | 28.06% | -7.44% |
On December 7, 2025, Confluent, Inc. entered into a merger agreement under which a subsidiary of International Business Machines Corporation will merge with and into Confluent, leaving Confluent as a wholly owned IBM subsidiary. At a special online shareholder meeting held on February 12, 2026, a quorum was achieved with holders of 247,889,521 shares present or represented by proxy out of 356,430,665 shares entitled to vote.
Shareholders approved the adoption of the merger agreement with 687,954,937 votes in favor, 339,860 against, and 91,336 abstaining, and also backed on an advisory basis the compensation arrangements for Confluent’s named executive officers related to the transaction. With the key shareholder approvals secured and the adjournment proposal rendered moot, the parties indicated that the merger is expected to close by mid-2026, subject to remaining conditions, marking a significant step toward Confluent’s integration into IBM’s enterprise software portfolio.
The most recent analyst rating on (CFLT) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Confluent stock, see the CFLT Stock Forecast page.
On December 7, 2025, Confluent entered into a merger agreement under which an IBM subsidiary will merge with and into Confluent, leaving Confluent as the surviving corporation and a wholly owned IBM unit, with shareholders scheduled to vote on the deal at a February 12, 2026 special meeting. Ahead of that vote, the company disclosed that it has received 17 demand letters and faces two New York state court lawsuits, filed on January 21 and 22, 2026, alleging that its January 9, 2026 definitive proxy statement contains misleading or omitted material information regarding the transaction; while Confluent denies all allegations and maintains that its disclosures fully comply with applicable law, it is voluntarily issuing supplemental financial and valuation-related disclosures, including additional detail on Morgan Stanley’s analyses and precedent transaction multiples, in an effort to moot the claims and reduce litigation risk and cost without admitting any wrongdoing.
The most recent analyst rating on (CFLT) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Confluent stock, see the CFLT Stock Forecast page.
Confluent, Inc. disclosed that it entered into a merger agreement on December 7, 2025 with International Business Machines Corporation (IBM) under which a wholly owned IBM subsidiary, Corvo Merger Sub, Inc., will be merged into Confluent, leaving Confluent as a wholly owned subsidiary of IBM. The transaction moved a step closer to completion when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on January 12, 2026, removing a key U.S. antitrust hurdle, though the deal still depends on additional regulatory clearances in other jurisdictions and approval by Confluent shareholders at a special meeting scheduled for February 12, 2026, signaling continued but not yet finalized progress toward IBM’s acquisition of the data-streaming company.
The most recent analyst rating on (CFLT) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Confluent stock, see the CFLT Stock Forecast page.
On December 7, 2025, Confluent, Inc. announced a merger agreement with IBM, under which IBM will acquire Confluent for $31 per share, valuing the company at $11 billion. The merger, expected to close by mid-2026, will make Confluent a wholly owned subsidiary of IBM, enhancing IBM’s capabilities in data streaming and AI. The acquisition aligns with IBM’s strategy to expand its hybrid cloud and AI offerings, and is expected to drive substantial product synergies and operational efficiencies. Confluent’s shareholders, representing 62% of the voting power, have agreed to vote in favor of the merger.
The most recent analyst rating on (CFLT) stock is a Sell with a $24.00 price target. To see the full list of analyst forecasts on Confluent stock, see the CFLT Stock Forecast page.